PURE Biomanufacturing: Secure, Pandemic-Adaptive Biomanufacturing

Abstract

Biopharmaceutical production systems and processes are vulnerable to cyberattacks from sophisticated adversaries. Therefore, it is imperative to start building biopharmaceutical manufacturing systems that offer verifiable formalism and transform the current state of security across all production stages.